Hurry up and wait: Is accelerated approval of new cancer drugs in the best interests of cancer patients?

被引：8
|
作者：
Schilsky, RL [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 20期
关键词：
D O I：
10.1200/JCO.2003.07.942
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3718 / 3720
页数：3
相关论文
共 50 条
  • [1] Lessons Learned From the Accelerated Approval of Cancer Drugs
    Gyawali, Bishal
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (07) : 441 - 443
  • [2] Accelerated approval seen as triumph and roadblock for cancer drugs
    Susman, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (20) : 1495 - 1496
  • [3] Early Accelerated Approval for Highly Targeted Cancer Drugs
    Chabner, Bruce A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12): : 1087 - 1089
  • [4] Hurry up and wait: The effect of wait time on survival in non-small cell lung cancer
    Gould, MK
    Ghaus, S
    CHEST, 2005, 128 (04) : 170S - 171S
  • [5] National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval
    Cliff, Edward R. Scheffer
    Rome, Rachel S.
    Kesselheim, Aaron S.
    Rome, Benjamin N.
    JAMA NETWORK OPEN, 2023, 6 (11) : E2343285
  • [6] New treatment for patients with advanced ovarian cancer receives accelerated approval
    Printz, Carrie
    CANCER, 2017, 123 (08) : 1286 - 1287
  • [7] The Accelerated Approval Program for Cancer Drugs - Finding the Right Balance
    Gyawali, Bishal
    Kesselheim, Aaron S.
    Ross, Joseph S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (11): : 968 - 971
  • [8] Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval
    Gyawali, Bishal
    Hey, Spencer Phillips
    Kesselheim, Aaron S.
    JAMA INTERNAL MEDICINE, 2019, 179 (07) : 906 - 913
  • [9] Wait and Hurry Up: Radiation Therapy for Prostate Cancer During the COVID-19 Pandemic
    Hoffman, Karen E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (02): : 340 - 340
  • [10] Global consequences of the US FDA's accelerated approval of cancer drugs
    Akhade, Amol
    Sirohi, Bhawna
    Gyawali, Bishal
    LANCET ONCOLOGY, 2022, 23 (02): : 201 - 203
12345